Summary of Purpose
Despite several scientific and technological advances, there is no single neuroprotective treatment that can reverse the brain damage after acute ischemic stroke (AIS). Neuroactive steroids are cholesterol-derived hormones that have the ability to modulate the normal and pathologic nervous system employing genomic and non genomic mechanisms. In this work, we first investigated if AIS affects the plasma...Read More →
The following dates are available for this trial. Trial information last updated on 22 September 2016.
|1 Jun 2014||9 Sep 2016||1 Dec 2014||1 Dec 2014||1 Sep 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case Control
- Perspective: Prospective
- Sampling: Probability Sample